Market Currents
Bayer (BAYRY.PK -2%) and Regeneron (REGN -1%) lose their U.K. patent fight on Eylea, a potential...
-
Thursday, March 22, 2012, 1:00 PM ETBayer (BAYRY.PK -2%) and Regeneron (REGN -1%) lose their U.K. patent fight on Eylea, a potential blockbuster VEGF Tarp-Eye treatment produced jointly by the two companies. A London Court has ruled that the drug infringes a patent held by Roche (RHHBY.PK -1.4%) subsidiary Genentech.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
